ONECUT2 and neoplasm: Considering antitumor activity, the cRGD-CL/ pshOC-2 lipoplexes (i.v.)treated mice showed the best inhibition rates in tumor weight (67.6%) and volume (66.2%), as well as in the expression of OC-2 (36.8%) than the other groups (Figure 6).